Olivier B - Search Results

1

The 5-HT_1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivity.

Korte SM, Prins J, Van den Bergh FS, Oosting RS, Dupree R, Korte-Bouws GA, Westphal KG, Olivier B, Denys DA, Garland A, Güntürkün O. Korte SM, et al. Among authors: olivier b. Eur J Pharmacol. 2017 Jan 5;794:257-269. doi: 10.1016/j.ejphar.2016.11.024. Epub 2016 Nov 17. Eur J Pharmacol. 2017. PMID: 27866999

2

The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl)piperazine hydrochloride and 8-hydroxy-2-(di-n-propylamino)tetralin on resident intruder aggression in the rat.

Mos J, Olivier B, Poth M, van Aken H. Mos J, et al. Among authors: olivier b. Eur J Pharmacol. 1992 Mar 3;212(2-3):295-8. doi: 10.1016/0014-2999(92)90348-8. Eur J Pharmacol. 1992. PMID: 1534769

3

The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects.

Groenink L, Van der Gugten J, Verdouw PM, Maes RA, Olivier B. Groenink L, et al. Among authors: olivier b. Eur J Pharmacol. 1995 Jul 4;280(2):185-93. doi: 10.1016/0014-2999(95)00209-4. Eur J Pharmacol. 1995. PMID: 7589185

4

The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor.

Groenink L, Van der Gugten J, Mos J, Maes RA, Olivier B. Groenink L, et al. Among authors: olivier b. Eur J Pharmacol. 1995 Jan 16;272(2-3):177-83. doi: 10.1016/0014-2999(94)00645-n. Eur J Pharmacol. 1995. PMID: 7713161

5

Discriminative stimulus effect of flesinoxan: effect of 5-HT1A antagonists and PCPA.

Ybema CE, Slangen JL, Olivier B. Ybema CE, et al. Among authors: olivier b. Pharmacol Biochem Behav. 1994 Apr;47(4):957-62. doi: 10.1016/0091-3057(94)90303-4. Pharmacol Biochem Behav. 1994. PMID: 8029269

6

Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan.

Ybema CE, Olivier B, Mos J, Tulp MT, Slangen JL. Ybema CE, et al. Among authors: olivier b. Eur J Pharmacol. 1994 Apr 21;256(2):141-7. doi: 10.1016/0014-2999(94)90238-0. Eur J Pharmacol. 1994. PMID: 8050464

7

The effects of dorsal raphe administration of eltoprazine, TFMPP and 8-OH-DPAT on resident intruder aggression in the rat.

Mos J, Olivier B, Poth M, Van Oorschot R, Van Aken H. Mos J, et al. Among authors: olivier b. Eur J Pharmacol. 1993 Jul 20;238(2-3):411-5. doi: 10.1016/0014-2999(93)90877-k. Eur J Pharmacol. 1993. PMID: 8405111

8

Stress-induced hyperthermia as a putative anxiety model.

Zethof TJ, Van der Heyden JA, Tolboom JT, Olivier B. Zethof TJ, et al. Among authors: olivier b. Eur J Pharmacol. 1995 Dec 27;294(1):125-35. doi: 10.1016/0014-2999(95)00520-x. Eur J Pharmacol. 1995. PMID: 8788424

9

Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol.

Mos J, van Aken HH, van Oorschot R, Olivier B. Mos J, et al. Among authors: olivier b. Eur Neuropsychopharmacol. 1996 Mar;6(1):1-7. doi: 10.1016/0924-977x(95)00051-p. Eur Neuropsychopharmacol. 1996. PMID: 8866931

10

5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus.

Compaan JC, Groenink L, van der Gugten J, Maes RA, Olivier B. Compaan JC, et al. Among authors: olivier b. Eur J Neurosci. 1996 Nov;8(11):2340-7. doi: 10.1111/j.1460-9568.1996.tb01197.x. Eur J Neurosci. 1996. PMID: 8950098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters